Notice: This company has been marked as potentially delisted and may not be actively trading. Vaccitech (VACC) News Today Add Compare Share Share Headlines Stock AnalysisCompetitorsHeadlinesInsider TradesOwnershipTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Real-World Data on the RSV Vaccine for Older AdultsNovember 12, 2024 | msn.comBarinthus Bio completes enrolment in hepatitis B and prostate cancer vaccine trialsOctober 2, 2024 | finance.yahoo.comBuy Rating Affirmed on Barinthus Biotherapeutics Amid Promising Clinical Trials and Therapeutic AdvancesOctober 1, 2024 | markets.businessinsider.comBarinthus Bio Completes Enrollment for Phase 2b HBV003 Clinical Trial in Chronic Hepatitis B and Phase 1 PCA001 Clinical Trial in Prostate CancerOctober 1, 2024 | markets.businessinsider.comStrong Buy Rating for Barinthus Biotherapeutics Amid Promising Trials in Celiac and Hepatitis B TherapiesSeptember 26, 2024 | markets.businessinsider.comVaccitech (NASDAQ:VACC) Trading Down 0.7%Vaccitech (NASDAQ:VACC) Trading Down 0.7%August 13, 2024 | marketbeat.comBuy Rating Reaffirmed for Barinthus Biotherapeutics Amid Promising Clinical AdvancementsAugust 12, 2024 | markets.businessinsider.comBRNS Stock Earnings: Barinthus Biotherapeutics Misses EPS for Q2 2024August 9, 2024 | markets.businessinsider.comHow real are the threats to the US dollar?July 31, 2024 | uk.finance.yahoo.comZoster Vaccine Market to Reach $9.1 Billion by 2033; Increasing Cases of Herpes Zoster Drives the Market's GrowthJuly 29, 2024 | finance.yahoo.comM&G Plc Makes New $25.99 Million Investment in Vaccitech plc (NASDAQ:VACC)M&G Plc purchased a new stake in Vaccitech plc (NASDAQ:VACC - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 5,197,349 shares of the company's stock, valued at approximately $25,987,000July 20, 2024 | marketbeat.comVaccitech (NASDAQ:VACC) Shares Down 0.4% Vaccitech (NASDAQ:VACC) Trading Down 0.4%June 27, 2024 | marketbeat.comVaccitech (NASDAQ:VACC) Trading Down 5.5%Vaccitech (NASDAQ:VACC) Stock Price Down 5.5%June 5, 2024 | marketbeat.comBarinthus Bio to Present VTP-300 Clinical Data Updates at EASL Congress 2024May 22, 2024 | markets.businessinsider.comBuy Rating for Barinthus Biotherapeutics Backed by Strong Financials and Promising Clinical TrialsMay 17, 2024 | markets.businessinsider.comWhat is AstraZeneca Vaccine? Know the Recently Discovered Side Effects of the COVID-19 AntibodyApril 30, 2024 | msn.comBuy Rating on Barinthus Biotherapeutics Backed by Promising Clinical Trials and Strong Valuation ProspectsApril 19, 2024 | markets.businessinsider.comLondon is a bad place to raise money, says life sciences tsar Sir John BellApril 6, 2024 | msn.comArbutus Biopharma Corporation (ABUS) Q4 2023 Earnings Call TranscriptMarch 2, 2024 | seekingalpha.comPositive Clinical Outlook and Strong Capital Position Justify Buy Rating for Barinthus BiotherapeuticsJanuary 8, 2024 | markets.businessinsider.comBarinthus Biotherapeutics: Barinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate MilestonesJanuary 8, 2024 | finanznachrichten.deBarinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate MilestonesJanuary 5, 2024 | finance.yahoo.comBuy Rating for Barinthus Biotherapeutics: Promising Pipeline and Strategic Partnerships Signal Investment OpportunityDecember 22, 2023 | markets.businessinsider.comBarinthus Biotherapeutics Collaborates With CEPI And University Of Oxford For New MERS VaccineDecember 21, 2023 | markets.businessinsider.comNew partnership aims to advance vaccine against MERS coronavirusDecember 21, 2023 | finance.yahoo.comInfluenza Vaccine Market to grow by USD 2.93 billion from 2022 to 2027; North America to account for 54% of market growth - TechnavioDecember 13, 2023 | finance.yahoo.comAnalysts’ Top Healthcare Picks: Barinthus Biotherapeutics (BRNS), Anavex Life Sciences (AVXL)November 28, 2023 | markets.businessinsider.comBarinthus Biotherapeutics plc (BRNS)November 15, 2023 | finance.yahoo.comBarinthus Bio Reports Third Quarter 2023 Financial Results and Recent Corporate DevelopmentsNovember 9, 2023 | finance.yahoo.comBarinthus Biotherapeutics Plc. - ADRNovember 8, 2023 | money.usnews.comBarinthus stock falls 18%, day after changing name from VaccitechNovember 7, 2023 | msn.comVaccitech rebrands as Barinthus, plans to present data at AASLD meetingNovember 6, 2023 | msn.comVaccitech Renames as Barinthus Biotherapeutics to Highlight Strategic Evolution into a T Cell Immunotherapy Company Targeting Chronic Infectious Diseases, Autoimmunity, and CancerNovember 6, 2023 | finance.yahoo.comSIRI, EC and PBTS among pre-market losersSeptember 28, 2023 | seekingalpha.comMorgan Stanley Downgrades VaccitechSeptember 26, 2023 | 247wallst.comInnovative Therapeutic Cancer Vaccines Drive Unprecedented Growth in Global Cancer Vaccines Market to 2028September 26, 2023 | uk.finance.yahoo.comVaccitech surges despite Morgan Stanley downgradeSeptember 26, 2023 | seekingalpha.comVaccitech plc (NASDAQ:VACC) surges 85%; individual investors who own 44% shares profited along with institutionsSeptember 26, 2023 | finance.yahoo.comGlobal Cancer Vaccines Market to Skyrocket, Projected to Reach $12.1 Billion by 2028September 25, 2023 | benzinga.comHealth Care Up on Defensive Bets -- Health Care RoundupSeptember 25, 2023 | marketwatch.comMorgan Stanley Downgrades Vaccitech plc - ADR (VACC)September 25, 2023 | msn.comVaccitech Shares Surge as Alliance Global Initiates CoverageSeptember 25, 2023 | marketwatch.comTrading was temporarily halted for "VACC" at 12:09 PM with a stated reason of "LULD pause."September 25, 2023 | marketbeat.comVaccitech to Host KOL Webinar on Seeking a Functional Cure for Chronic Hepatitis B on September 20, 2023September 13, 2023 | finance.yahoo.comArbutus BioPharma narrows research focus to extend cash runwaySeptember 12, 2023 | bizjournals.comVaccitech plc: Vaccitech Reports Second Quarter 2023 Financial Results and Recent Corporate DevelopmentsAugust 10, 2023 | finanznachrichten.deVaccitech Reports Second Quarter 2023 Financial Results and Recent Corporate DevelopmentsAugust 10, 2023 | finance.yahoo.comVaccitech (NASDAQ:VACC) shareholders have endured a 50% loss from investing in the stock a year agoAugust 9, 2023 | finance.yahoo.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Vaccitech Plc (VACC) and Aeglea Biotherapeutics (AGLE)June 22, 2023 | markets.businessinsider.comAnalyst Expectations for Vaccitech's FutureJune 13, 2023 | markets.businessinsider.com Get Vaccitech News Delivered to You Automatically Sign up to receive the latest news and ratings for VACC and its competitors with MarketBeat's FREE daily newsletter. Email Address Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news. Register For The Webinar To Discover VACC Media Mentions By Week VACC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VACC News Sentiment▼0.000.55▲Average Medical News Sentiment VACC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VACC Articles This Week▼10▲VACC Articles Average Week Get Vaccitech News Delivered to You Automatically Sign up to receive the latest news and ratings for VACC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies scPharmaceuticals News Today Verastem News Today Heron Therapeutics News Today Gossamer Bio News Today Eledon Pharmaceuticals News Today Nanobiotix News Today Atossa Therapeutics News Today Galectin Therapeutics News Today DiaMedica Therapeutics News Today Incannex Healthcare News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VACC) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccitech plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccitech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VACC Stock Alerts